Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D3 receptor-selective full agonist ligand

Bioorganic & Medicinal Chemistry
2012.0

Abstract

This work describes the identification of a novel class of octahydrobenzo[f]quinolines as dopamine D(3)-selective full agonists. We developed a facile method that utilizes Suzuki coupling for easy incorporations of various substituted pendant rings into the scaffold. A small focused library of octahydrobenzo[f]quinolines 5 was synthesized, and these compounds demonstrated at least 14-fold D(2)-like selectivity over D(1) in native porcine striatal tissue. Furthermore, n-propyl analog 5f was found to be a high affinity (K(i)=1.1 nM) D(3) dopamine full agonist with 145-fold selectivity over the D(2) receptor and about 840-fold selectivity over the D(1) receptor.

Knowledge Graph

Similar Paper

Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D3 receptor-selective full agonist ligand
Bioorganic & Medicinal Chemistry 2012.0
Facile synthesis of octahydrobenzo[h]isoquinolines: Novel and highly potent D1 dopamine agonists
Bioorganic & Medicinal Chemistry 2010.0
trans-2,3-Dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline:  Synthesis, Resolution, and Preliminary Pharmacological Characterization of a New Dopamine D<sub>1</sub>Receptor Full Agonist
Journal of Medicinal Chemistry 2006.0
Synthesis and SAR study of a novel series of dopamine receptor agonists
Bioorganic &amp; Medicinal Chemistry 2014.0
Synthesis and dopaminergic activity of 2-substituted octahydrobenzo[f]quinolines
Journal of Medicinal Chemistry 1989.0
N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines:  Synthesis and Adrenergic and Dopaminergic Activity Studies
Journal of Medicinal Chemistry 1998.0
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands
Journal of Medicinal Chemistry 1988.0
Assessment of dopamine D1 receptor affinity and efficacy of three tetracyclic conformationally-restricted analogs of SKF38393
Bioorganic &amp; Medicinal Chemistry 2011.0
8,9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline:  A Potent Full Dopamine D<sub>1</sub> Agonist Containing a Rigid β-Phenyldopamine Pharmacophore
Journal of Medicinal Chemistry 1996.0
Binding and Preliminary Evaluation of 5-Hydroxy- and 10-Hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as Dopamine Receptor Ligands
Journal of Medicinal Chemistry 2000.0